Navigation Links
Enzymatics Reports Latest Growth Figures; Confirms Massachusetts' Emerging Role as Leading Bio-manufacturing Center
Date:6/9/2011

BEVERLY, Mass., June 9, 2011 /PRNewswire/ -- Enzymatics, Inc. announced today that the company, whose revenues have doubled every year since 2007, is forecasting triple the revenue in 2011 over 2010 figures.  It is also expanding its corporate offices and manufacturing facility in Beverly, Massachusetts.  The move is one of several significant milestones for the five year-old, privately held firm that supplies biological reagents as well as bio-processing consulting services to the international scientific and healthcare markets.  It also demonstrates that Massachusetts is no longer just a biotech R&D nursery and is quickly becoming an international center for biotech manufacturing.

Enzymatics' proprietary manufacturing process produces commercial quantities of enzymes measurably superior in purity and consistency to those created in small batches for the research field — but at a much lower cost.  The timing couldn't be better as national and international bioscience and pharmaceutical companies rush to create genomic diagnostics and bio-ceutical drug therapies for mass-market distribution.  Reagents are critical components of these products and in Enzymatics, their manufacturers have found an ideal partner supplier that can scale up to meet large production levels while exceeding purity standards and keeping costs down.  

"Our growth and expansion are a great confirmation that we had the right vision at exactly the right time," states Enzymatics Co-Founder and President Chris Benoit.  "It's been an incredible ride that's about to get even more exciting as we expand our presence in larger, international markets."  The company is currently establishing its first full-service overseas office in Europe. Enzymatics now supports a full time staff of more than 50 and is actively looking to fill an additional 15 positions.  

When asked to share his own perspective on the company's progress, Co-Founder and CEO Stephen Picone replied, "You can sense the future here...We're perfecting new manufacturing technologies built on our core competencies.  And the key collaborations we're setting up will lay the groundwork for the development of novel enzymes.  Both of these initiatives will add a great deal of value to our customer's businesses."

ABOUT ENZYMATICS:  Enzymatics is a leading biotechnology and biosciences manufacturing company that delivers ISO 13485-compliant enzymes of unrivaled purity, consistency, and value to the healthcare and bioscience industries.  For more information, please visit www.enzymatics.com.

Lisa Lazarczyk
781-646-0667 or lisa@lazpr.com


'/>"/>
SOURCE Enzymatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Reports 18% Increase in Net Income on 24% Increase in Sales
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Cyberonics Reports Record Fiscal 2011 Results and Provides Fiscal 2012 Guidance
5. China Medical Technologies Reports Fourth Fiscal Quarter and Full Fiscal Year Financial Results
6. Encision Reports Profitable Fourth Quarter and Fiscal Year 2011 Results
7. Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
8. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
9. China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results
10. HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011
11. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> Research and ...
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest ... is the first of its kind in the ... tattoos through advanced laser treatment. The physician-owned and ... Suncoast by storm with its revitalizing ... and advanced multi-wavelength Astanza Trinity technology. ...
(Date:2/5/2016)... Feb. 5, 2016 Dehaier Medical Systems ... the "Company"), which develops, markets and sells medical ... China and international markets, today ... aims to concentrate the Company,s resources to develop ... business and to focus more on its major ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... Nutrition into the Food & Beverage and Dietary Supplement ... partner throughout Canada and USA geographies east of the Rocky Mountains since 2012. ...
(Date:2/8/2016)... ... 2016 , ... Brenton Engineering , powered by Pro ... wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This new solution ... or fully-automatic case packing with a small footprint, rugged, highly flexible, and cost-effective ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local ... the greater Venice, FL area, has initiated a fundraiser for a two year ... just four days after Christmas. To support this beautiful child who is facing ...
(Date:2/8/2016)... ... ... FileHold's document management software has been implemented by DocuSyst ... for FileHold software that is pay per user subscription-based and also does on-premise ... web services API. DocuSyst also advises clients on fully functioning back up technologies ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua Rosenthal, PhD, ... healthcare companies can use newly released government data on populations and physicians to ... intervene and capture the value they create to succeed in new economic models ...
Breaking Medicine News(10 mins):